These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9619374)

  • 1. Regulatory role of interleukin 10 in joint inflammation and cartilage destruction in murine streptococcal cell wall (SCW) arthritis. More therapeutic benefit with IL-4/IL-10 combination therapy than with IL-10 treatment alone.
    Lubberts E; Joosten LA; Helsen MM; van den Berg WB
    Cytokine; 1998 May; 10(5):361-9. PubMed ID: 9619374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major role for interleukin 1 but not for tumor necrosis factor in early cartilage damage in immune complex arthritis in mice.
    Van Lent PL; Van De Loo FA; Holthuysen AE; Van Den Bersselaar LA; Vermeer H; Van Den Berg WB
    J Rheumatol; 1995 Dec; 22(12):2250-8. PubMed ID: 8835558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shift from toll-like receptor 2 (TLR-2) toward TLR-4 dependency in the erosive stage of chronic streptococcal cell wall arthritis coincident with TLR-4-mediated interleukin-17 production.
    Abdollahi-Roodsaz S; Joosten LA; Helsen MM; Walgreen B; van Lent PL; van den Bersselaar LA; Koenders MI; van den Berg WB
    Arthritis Rheum; 2008 Dec; 58(12):3753-64. PubMed ID: 19035506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis.
    Koenders MI; Kolls JK; Oppers-Walgreen B; van den Bersselaar L; Joosten LA; Schurr JR; Schwarzenberger P; van den Berg WB; Lubberts E
    Arthritis Rheum; 2005 Oct; 52(10):3239-47. PubMed ID: 16200598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell dependence of chronic destructive murine arthritis induced by repeated local activation of Toll-like receptor-driven pathways: crucial role of both interleukin-1beta and interleukin-17.
    Joosten LA; Abdollahi-Roodsaz S; Heuvelmans-Jacobs M; Helsen MM; van den Bersselaar LA; Oppers-Walgreen B; Koenders MI; van den Berg WB
    Arthritis Rheum; 2008 Jan; 58(1):98-108. PubMed ID: 18163514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local interleukin-12 gene transfer promotes conversion of an acute arthritis to a chronic destructive arthritis.
    Joosten LA; Heuvelmans-Jacobs M; Lubberts E; van de Loo FA; Bakker AC; Helsen MM; Richards CD; van den Berg WB
    Arthritis Rheum; 2002 May; 46(5):1379-89. PubMed ID: 12115246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1β, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: rationale for combination treatment during arthritis.
    Koenders MI; Marijnissen RJ; Devesa I; Lubberts E; Joosten LA; Roth J; van Lent PL; van de Loo FA; van den Berg WB
    Arthritis Rheum; 2011 Aug; 63(8):2329-39. PubMed ID: 21520013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
    Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced cartilage proteoglycan loss during zymosan-induced gonarthritis in NOS2-deficient mice and in anti-interleukin-1-treated wild-type mice with unabated joint inflammation.
    van de Loo FA; Arntz OJ; van Enckevort FH; van Lent PL; van den Berg WB
    Arthritis Rheum; 1998 Apr; 41(4):634-46. PubMed ID: 9550472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 reduces cartilage destruction during experimental arthritis. A study in interleukin-6-deficient mice.
    van de Loo FA; Kuiper S; van Enckevort FH; Arntz OJ; van den Berg WB
    Am J Pathol; 1997 Jul; 151(1):177-91. PubMed ID: 9212744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction.
    Lubberts E; Joosten LA; van Den Bersselaar L; Helsen MM; Bakker AC; van Meurs JB; Graham FL; Richards CD; van Den Berg WB
    J Immunol; 1999 Oct; 163(8):4546-56. PubMed ID: 10510398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra.
    Joosten LA; Helsen MM; van de Loo FA; van den Berg WB
    Arthritis Rheum; 2008 Feb; 58(2 Suppl):S110-22. PubMed ID: 18240201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of cartilage damage by overexpression of T cell interleukin-17A in experimental arthritis in mice deficient in interleukin-1.
    Koenders MI; Lubberts E; Oppers-Walgreen B; van den Bersselaar L; Helsen MM; Kolls JK; Joosten LA; van den Berg WB
    Arthritis Rheum; 2005 Mar; 52(3):975-83. PubMed ID: 15751058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral delivery of group A streptococcal cell walls augments circulating TGF-beta and suppresses streptococcal cell wall arthritis.
    Chen W; Jin W; Cook M; Weiner HL; Wahl SM
    J Immunol; 1998 Dec; 161(11):6297-304. PubMed ID: 9834119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined blockade of granulocyte-macrophage colony stimulating factor and interleukin 17 pathways potently suppresses chronic destructive arthritis in a tumour necrosis factor alpha-independent mouse model.
    Plater-Zyberk C; Joosten LA; Helsen MM; Koenders MI; Baeuerle PA; van den Berg WB
    Ann Rheum Dis; 2009 May; 68(5):721-8. PubMed ID: 18495731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different roles of tumour necrosis factor alpha and interleukin 1 in murine streptococcal cell wall arthritis.
    Kuiper S; Joosten LA; Bendele AM; Edwards CK; Arntz OJ; Helsen MM; Van de Loo FA; Van den Berg WB
    Cytokine; 1998 Sep; 10(9):690-702. PubMed ID: 9770330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of interleukin 1 in antigen-induced exacerbations of murine arthritis.
    van de Loo AA; Arntz OJ; Bakker AC; van Lent PL; Jacobs MJ; van den Berg WB
    Am J Pathol; 1995 Jan; 146(1):239-49. PubMed ID: 7856731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of cytokines in osteoarthritis pathophysiology.
    Fernandes JC; Martel-Pelletier J; Pelletier JP
    Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of interleukin-18 in experimental group B streptococcal arthritis.
    Tissi L; McRae B; Ghayur T; von Hunolstein C; Orefici G; Bistoni F; Puliti M
    Arthritis Rheum; 2004 Jun; 50(6):2005-13. PubMed ID: 15188378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.